Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

Cancer drug helps prevent hypertensive heart disease

A promising cancer treatment drug can restore function of a heart en route to failure from high blood pressure, researchers at UT Southwestern Medical Center have found.

31 May 2011

Woman's risk of developing diabetes during pregnancy can be identified seven years before

A woman's risk of developing diabetes during pregnancy can be identified up to seven years before she becomes pregnant based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.

30 May 2011

High blood pressure becoming more common in young adults: Study

According to a new study about one in five young adults may have high blood pressure. The researchers from the University of North Carolina at Chapel Hill analyzed blood pressure data from the National Longitudinal Study of Adolescent Health, called Add Health, and compared it with data from the National Health and Nutrition Examination Survey, commonly referred to as NHANES. They focused specifically on the information about adults age 24 to 32.

29 May 2011

AHRQ: 94% of women hospitalized for pregnancy and delivery in the U.S. had complications

Over 9 out of every 10 women giving birth in the United States had some complication in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

27 May 2011

ASH announces approval of official health care taxonomy code for Designated Specialists

Today the American Society of Hypertension, Inc. (ASH) and the ASH Specialist Program Inc. announced the approval of an official health care taxonomy code for Designated Specialists in Clinical Hypertension from the American Medical Association National Uniform Claims Committee.

27 May 2011

Disparities based on race and ethnic origin exist in every aspect of stroke care

Disparities between racial/ethnic minorities and whites cross all aspects of stroke care, according to an American Heart Association/American Stroke Association scientific statement.

27 May 2011

Leukemia, psoriasis drugs may treat vascular diseases

A drug that has been on the market for decades to treat leukemia and skin disorders such as acne and psoriasis may be a possible therapy for vascular diseases, including atherosclerosis and hypertension, which can lead to heart attack or stroke.

27 May 2011

Long-term exposure to estrogen increases high blood pressure in women

For many years doctors believed the estrogen women consumed in the form of oral contraceptives and hormone replacement therapy pills was good for their patients' hearts. Recent studies however have shown that long-term exposure to estrogen can be a danger to women as it has been associated with high blood pressure, a key link to heart- and brain-attacks.

27 May 2011

New Hypertension Management Program study results revealed at ASH scientific meeting

High blood pressure - the silent killer - is taking a hit from a new, ground-breaking treatment program from the Heart and Stroke Foundation of Ontario.

26 May 2011

Ardea reports additional results from lesinurad-allopurinol Phase 2b study in hyperuricemia, gout

Ardea Biosciences, Inc. announced that additional positive clinical and preclinical results from its development program of lesinurad, the Company's lead product candidate for the treatment of hyperuricemia and gout, were presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism in London, UK.

26 May 2011

Routine assessment can help predict risk of developing diabetes during pregnancy before seven years

26 May 2011

NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer

A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA plus prednisone compared to patients treated with prednisone plus placebo.

26 May 2011

NIH-funded analysis finds 19% of young adults with high blood pressure

Roughly 19 percent of young adults may have high blood pressure, according to an analysis of the National Longitudinal Study of Adolescent Health, which is supported by the National Institutes of Health.

26 May 2011

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

GE Healthcare today announced 510k clearance of CoreScan - a widely-accessible application dedicated to quickly and accurately quantifying visceral adipose tissue, or visceral "belly" fat, during body composition analysis.

26 May 2011

MKK4 enzyme may prevent arrhythmias linked with cardiac hypertrophy

Scientists have discovered an important enzyme molecule that may prevent fatal cardiac disorders associated with cardiac hypertrophy - the leading cause of sudden cardiac death in young athletes.

25 May 2011

Obesity and diabetes rates continue to rise despite decline in consumption of sweeteners

A comprehensive review of research focusing on the debate between High Fructose Corn Syrup and other sweeteners presented today finds there is no evidence of any significant variation in the way the human body metabolizes HFCS as opposed to standard table sugar, or any difference in impact on risk factors for chronic disease.

25 May 2011

Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011

Takeda Global Research & Development Center, Inc. U.S., today announced results from three phase 3 studies of the investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone.

24 May 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Exelixis, Inc. today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology.

24 May 2011

Expert review of respiratory medicine on pulmonary hypertension

Pulmonary hypertension (PH) is a rare, often incurable lung disorder that affects individuals of all ages, races and ethnic backgrounds. In the recent 4th World Conference on Pulmonary Hypertension held by the WHO, PH was classified into five groups based on its causes, highlighting both the magnitude of conditions associated with PH and how little we know of the etiology in many cases.

23 May 2011

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).

23 May 2011

Hypertension (High Blood Pressure) News and Research

Further Reading

Cancer drug helps prevent hypertensive heart disease

Woman's risk of developing diabetes during pregnancy can be identified seven years before

High blood pressure becoming more common in young adults: Study

AHRQ: 94% of women hospitalized for pregnancy and delivery in the U.S. had complications

ASH announces approval of official health care taxonomy code for Designated Specialists

Disparities based on race and ethnic origin exist in every aspect of stroke care

Leukemia, psoriasis drugs may treat vascular diseases

Long-term exposure to estrogen increases high blood pressure in women

New Hypertension Management Program study results revealed at ASH scientific meeting

Ardea reports additional results from lesinurad-allopurinol Phase 2b study in hyperuricemia, gout

Routine assessment can help predict risk of developing diabetes during pregnancy before seven years

NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer

NIH-funded analysis finds 19% of young adults with high blood pressure

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

MKK4 enzyme may prevent arrhythmias linked with cardiac hypertrophy

Obesity and diabetes rates continue to rise despite decline in consumption of sweeteners

Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Expert review of respiratory medicine on pulmonary hypertension

Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News